Table 3.

Time-dependent variables of the analysed intervention groups

Variable	Group A P-value x ± s	Group B P-value x ± s	Group C* P-value x ± s	Group D* P-value x ± s	Group E P-value x ± s	Group F P-value x ± s	Group G P-value x ± s	Group H P-value x ± s	Group I P-value x ± s	P-value (groups)
UDVA (logMAR)	< 0.001	0.002	< 0.001	< 0.001	0.068	< 0.001	< 0.001	< 0.001	0.019	0.204
Preintervention	0.58 ± 0.24	0.38 ± 0.36	0.48 ± 0.27	0.5 ± 0.28	0.38 ± 0.38	0.42 ± 0.32	0.44 ± 0.33	0.5 ± 0.31	0.36 ± 0.38	0.726
Postintervention	0.12 ± 0.27	0.16 ± 0.22	0.09 ± 0.20	0.10 ± 0.24	0.20 ± 0.30	0.03 ± 0.12	0.08 ± 0.16	0.08 ± 0.19	0.14 ± 0.27	< 0.001
CDVA (logMAR)	< 0.001	0.392	0.082	0.016	0.059	0.087	0.053	0.019	0.111	0.003
Preintervention	0.20 ± 0.31	0.08 ± 0.26	0.07 ± 0.25	0.09 ± 0.22	0.08 ± 0.40	0.03 ± 0.28	0.08 ± 0.21	0.10 ± 0.28	0.11 ± 0.24	0.043
Postintervention	0.03 ± 0.23	0.05 ± 0.18	0.02 ± 0.12	0.04 ± 0.20	-0.01 ± 0.15	-0.01 ± 0.08	0.01 ± 0.13	0.02 ± 0.15	0.07 ± 0.21	0.033
Sphere (D)	0.553	0.753	0.261	0.343	0.938	0.020	0.858	0.102	0.125	0.036
Preintervention	− 0.75 ± 4.61	− 0.01 ± 2.69	0.97 ± 3.80	1.12 ± 3.39	− 0.62 ± 6.02	1.21 ± 2.52	0.55 ± 2.13	− 1.33 ± 4.11	− 0.82 ± 1.69	0.140
Postintervention	− 0.16 ± 0.43	0.18 ± 0.52	0.06 ± 0.48	0.50 ± 1.67	− 0.50 ± 0.83	0.14 ± 0.29	0.63 ± 0.46	0.28 ± 0.45	− 0.05 ± 0.57	0.001
Cylinder (D)	0.004	0.736	0.747	0.093	0.457	< 0.001	0.153	0.002	0.602	0.073
Preintervention	− 0.95 ± 0.57	− 0.75 ± 0.69	− 0.64 ± 0.57	− 0.93 ± 1.23	− 0.74 ± 0.82	− 0.77 ± 0.54	− 0.64 ± 0.71	− 0.61 ± 0.38	− 0.89 ± 0.81	0.758
Postintervention	− 0.42 ± 0.38	− 0.70 ± 0.85	− 0.58 ± 0.55	− 0.61 ± 0.63	− 0.91 ± 0.66	− 0.28 ± 0.45	− 0.40 ± 0.45	− 0.24 ± 0.32	− 0.75 ± 0.72	0.003
UNVA (logMAR)	0.380	< 0.001	0.023	0.086	< 0.001	< 0.001	< 0.001	< 0.001	0.002	< 0.001
Preintervention	0.61 ± 0.32	0.83 ± 0.24	0.34 ± 0.31	0.39 ± 0.29	0.66 ± 0.28	0.48 ± 0.26	0.92 ± 0.20	1.08 ± 0.13	0.59 ± 0.26	< 0.001
Postintervention	0.89 ± 0.21	0.39 ± 0.27	0.19 ± 0.18	0.30 ± 0.22	0.23 ± 0.20	0.15 ± 0.18	0.23 ± 0.17	0.21 ± 0.20	0.18 ± 0.26	< 0.001
Add (D)	0.518	< 0.001	< 0.001	0.001	0.279	< 0.001	0.058	< 0.001	0.004	< 0.001
Preintervention	2.75 ± 0.15	2.34 ± 0.40	2.37 ± 0.81	2.23 ± 1.41	2.19 ± 0.84	2.45 ± 0.49	2.18 ± 0.84	2.40 ± 0.46	1.82 ± 1.26	0.239
Postintervention	2.58 ± 0.78	1.54 ± 0.74	0.73 ± 0.96	0.90 ± 0.84	1.93 ± 0.26	0.12 ± 0.36	1.28 ± 2.00	0.25 ± 0.62	1.14 ± 1.05	< 0.001
CNVA (logMAR)	0.050	0.349	0.509	0.019	0.027	0.837	0.190	0.363	0.015	0.015
Preintervention	0.17 ± 0.29	0.13 ± 0.28	0.09 ± 0.26	0.11 ± 0.22	0.11 ± 0.25	0.11 ± 0.16	0.17 ± 0.22	0.17 ± 0.27	0.21 ± 0.13	0.205
Postintervention	0.06 ± 0.14	0.09 ± 0.19	0.11 ± 0.14	0.17 ± 0.19	0.03 ± 0.12	0.11 ± 0.08	0.12 ± 0.14	0.13 ± 0.20	0.12 ± 0.20	< 0.001

Add near addition; CDVA corrected distance visual acuity; CNVA corrected near visual acuity; D diopters; logMAR logarithm of the minimum angle of resolution; UDVA uncorrected distance visual acuity; UNVA uncorrected near visual acuity; x ± s mean ± standard deviation

Group A: AcrySof SA60AT; Group B: SIFI Miniwell; Group C: LENTIS Mplus LS-313 MF30; Group D: LENTIS Mplus LS-313 MF15; Group E: AkkoLens Lumina; Group F: AT LISA Tri 839MP; Group G: Precizon Presbyopic; Group H: AcrySof IQ PanOptix; Group I: Tecnis Eyhance

*There was one patient whose left eye was included in Group C and the right eye in Group D